The Latest News in Veterinary Medicine
Dechra Introduces Levocrine Chewable TabletsDechra
Dechra Veterinary Products U.S. has announced the availability of Levocrine (levothyroxine sodium) Chewable Tablets to its endocrinology product line of Vetoryl (trilostane) Capsules and Felimazole (methimazole) Coated Tablets. Levocrine Chewable Tablets provide levothyroxine sodium to aid in the treatment of canine hypothyroidism. The products are available in 180 count and 1000 count bottles, with convenient doses ranging from 0.1 mg to 0.8 mg (also includes 1 mg). These products are available in the U.S. from most veterinary distributors. For more information, please visit dechra-us.com or call 866-933-2472.
Norbrook Introduces New Enroflox Injection for Dogs
Norbrook Laboratories, Ltd announced the introduction of Enroflox (enrofloxacin) Injection for Dogs 2.27%, a fluoroquinolone designed for the management of bacterial diseases, with broad-spectrum activity against both gram negative and gram positive bacteria, including those causing dermal, urinary, and respiratory tract infections. Each mL of injectable solution contains 22.7 mg of enrofloxacin. Enroflox Injection is available for dogs only and will be available in 20 mL and exclusive 100 mL vials to accommodate any size clinic. For more information, contact your products distributor or Norbrook, Inc at norbrookinc.com.
Virbac Announces Agreement with Eli Lilly and Company
Virbac Corporation has announced an agreement with Eli Lilly and Company to acquire major U.S. veterinary products currently marketed by Novartis Animal Health. Eli Lilly has agreed to divest these U.S. assets in connection with the U.S. Federal Trade Commission’s review of Eli Lilly’s pending acquisition of Novartis Animal Health worldwide. Under the terms of this agreement, Virbac would acquire a combination of titles and rights for the U.S. on trademarks, marketing authorizations, patents, know-how, customer lists, and other assets related to two major parasiticides for dogs: Sentinel Flavor Tabs and Sentinel Spectrum, currently marketed in the U.S. by Novartis Animal Health. For more information, please visit virbacvet.com.
IDEXX to Help Veterinary Community Strengthen the Bonds that Matter Most
IDEXX Laboratories, Inc has launched a comprehensive, multi-year initiative called Strengthen the Bonds, a framework designed to help veterinarians provide exceptional care to pets and improve the health of their practices. IDEXX’s Strengthen the Bonds framework features new research, education, and one-on-one support that veterinary practices can use to explore new ways of delivering care, fostering client loyalty and improving teamwork among staff. IDEXX provides a team of professionals dedicated to working with customers to understand the unique needs and challenges faced by their practice, and practices will benefit from an individualized plan that will help them achieve their care goals. For more information, please visit idexx.com/strengthenthebonds.
Putney Captures Enrofloxacin Flavored Tablet Market in Deals with National Distributors
Putney, Inc, a pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has launched Enrofloxacin Flavored Tablets with the three largest national veterinary distributors—Henry Schein Animal Health, MWI Veterinary Supply, and Patterson Veterinary. In combination with existing and new independent distributor partnerships and Putney’s direct sales, these agreements provide unrestricted distribution of Putney’s Enrofloxacin Flavored Tablets to veterinarians nationwide. The company states it is working with its distributors and veterinary customers to bring the benefits of generics to pet owners and their pets. For a complete list of Putney’s products and the distributors carrying them, visit putneyvet.com/products.
Please send any news, press releases, or information relevant to veterinary professionals to [email protected] for publication consideration in Today’s Veterinary News.